Evidence Paper Review

 Quick Explanation Copied

 Long Explanation

Core finding and evidence

This eLife study (published December 2025) demonstrates that C. elegans exhibits effort-discounting-like food choice. The authors elongated Comamonas bacteria with cephalexin, showing that: (1) pumping frequency is unchanged (p=0.92, d=0.03, n=66/60), but fat stores drop (p=3.2e-04, r=0.43), indicating more pumps per unit nutrient; (2) nutrition (protein/carb/lipid, all p>0.9) and odor attractiveness (azide-trapped T-maze, p=0.36, n=108) are unaffected; (3) in free-choice T-mazes, worms prefer normal bacteria at equal OD (I=+0.10, p=1.69e-03, n=137), are indifferent at OD 1.5 elongated (I=0.03, p=0.28, n=106), and prefer elongated at OD 2.0 (I=-0.17, p=2.06e-07, n=73) eLife effort discounting paper.

Strengths: quantitative economic prediction

The standout contribution is the derivation of a discount factor d(E)=2/3 from the indifference point, then out-of-sample prediction of novel indifference points at OD ratios 2:3 and 0.5:0.75 — both confirmed (one-way ANOVA across three novel ratios: F=0.83, p=0.44, η²≈0) Predicted indifference points confirmed. Patch-leaving kinetics show leaving rates (k_FB, k_BO) increase on elongated food while entry rates are unchanged (MANOVA p=8.77e-11), supporting a local-assessment mechanism rather than cross-arm comparison Kinetic mechanism of discounting.

Critical caveats

Dopamine paradox: dop-3 mutants show indifference (p=0.019), but cat-2 and dat-1 mutants are normal — authors acknowledge this is puzzling and consistent only with dop-3-specific signaling. Confounds: cephalexin elongation is a single manipulation; subtle unmeasured bacterial differences cannot be fully excluded. N2 laboratory bias: N2 has 50+ years of lab adaptation to easy-to-eat E. coli; only 5 wild isolates were tested with high variance, and DL238 behaved like N2 while JU775 was indifferent — genetic background effects are unresolved Dopamine mutants and wild isolates. Interpretive gap: "effort discounting-like" is phenomenological — whether the 302-neuron system computes subjective value or simply follows a local stimulus-response rule remains untested. This study builds on prior utility-maximization work showing GARP-consistent choice eLife utility maximization paper. COI: senior author has a financial interest in InVivo Biosystems (ScreenChip used in Fig. 1A) — low impact on the central T-maze findings but disclosed.

Verdict

Strong, well-controlled, quantitatively predictive behavioral study. The mechanism-level claims (dopamine role, subjective value) remain correlational and warrant caution; the behavioral phenomenon itself is robust.

 BGPT Paper Review

Study Novelty

First demonstration of effort-discounting-like behavior in a lower invertebrate with quantitative model-based prediction of novel indifference points; extends discounting phylogeny but builds on prior GARP work in the same system.

Scientific Quality

Exhaustive controls (nutrients, odor, pumping rate), full statistical reporting with effect sizes, out-of-sample predictions confirmed. Weaknesses: dop-3/cat-2/dat-1 inconsistency unexplained, only 5 wild isolates with high variance, COI in pumping-assay hardware.

Study Generality

Extends cost-benefit decision-making frameworks across ~600 My of evolutionary distance; implications for neuroeconomics, behavioral ecology, and discounting models broadly, though ecological validity in natural habitats is untested.

Study Usefulness

Provides a genetically tractable system with a quantified discount factor for dissecting effort-based choice; immediately useful for C. elegans neurogenetics and comparative discounting research.

Study Reproducibility

All raw data in Source data 1, analysis code in Source code 1, detailed methods, CGC strains, and full statistical table (Table 1) support independent replication.

Explanatory Depth

Strong behavioral-economic formalization and kinetic mechanism, but neural implementation (how 302 neurons compute discounted value, dop-3's specific role) remains speculative.